Yongjun Fang
Impact in
- Cancer Research top 10%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Hematology top 10%
- Acute Myeloid Leukemia Research
Papers in
-
- Epigenetics and DNA Methylation 8
- RNA modifications and cancer 5
-
- Acute Lymphoblastic Leukemia research 20
- Co-authors
- Liucheng Rong (18 shared papers)Yao Xue (16 shared papers)Meilin Wang (17 shared papers)Na Tong (16 shared papers)Peng Wu (5 shared papers)Zhengdong Zhang (11 shared papers)Qin Lu (10 shared papers)Yaping Wang (3 shared papers)
- Journals
- Cellular Physiology and Biochemistry (4 papers)Frontiers in Immunology (3 papers)Medicine (3 papers)Cell Death and Disease (3 papers)Gene (2 papers)
- Partner nations
- ChinaUnited StatesCanada
In The Last Decade
Yongjun Fang
68 papers receiving 842 citations
Peers
Comparison fields: 5 of 81
- Cancer Research 228
- Hematology 99
- Molecular Biology 385
- Public Health, Environmental and Occupational Health 139
- Biological Psychiatry 9
Countries citing papers authored by Yongjun Fang
This map shows the geographic impact of Yongjun Fang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yongjun Fang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yongjun Fang more than expected).
Fields of papers citing papers by Yongjun Fang
This network shows the impact of papers produced by Yongjun Fang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yongjun Fang. The network helps show where Yongjun Fang may publish in the future.
Co-authors
The 25 scholars most cited alongside Yongjun Fang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 76 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 89 | |
| 2 | Schizandrin A protects against cerebral ischemia-reperfusion injury by suppressing inflammation and oxidative stress and regulating the AMPK/Nrf2 pathway regulation. | 2019 | 74 |
| 3 | 2013 | 47 | |
| 4 | 2012 | 39 | |
| 5 | 2014 | 34 | |
| 6 | 2013 | 34 | |
| 7 | 2009 | 33 | |
| 8 | 2015 | 32 | |
| 9 | 2018 | 28 | |
| 10 | 2018 | 28 | |
| 11 | 2016 | 27 | |
| 12 | 2010 | 26 | |
| 13 | 2011 | 25 | |
| 14 | 2011 | 21 | |
| 15 | 2016 | 19 | |
| 16 | 2018 | 17 | |
| 17 | 2018 | 15 | |
| 18 | 2016 | 15 | |
| 19 | 2009 | 14 | |
| 20 | 2019 | 14 |
About Yongjun Fang
Yongjun Fang is a scholar working on Molecular Biology, Public Health, Environmental and Occupational Health, Hematology, Oncology and Pediatrics, Perinatology and Child Health, having authored 76 papers that have together received 855 indexed citations. Recurring topics across this work include Acute Lymphoblastic Leukemia research (20 papers), Epigenetics and DNA Methylation (8 papers), Childhood Cancer Survivors' Quality of Life (7 papers), Lymphoma Diagnosis and Treatment (7 papers), Acute Myeloid Leukemia Research (6 papers), RNA modifications and cancer (5 papers), Neuroblastoma Research and Treatments (4 papers) and Cancer-related molecular mechanisms research (4 papers). The work is most often cited by research in Cancer Research (228 citations), Hematology (99 citations), Molecular Biology (385 citations), Public Health, Environmental and Occupational Health (139 citations) and Biological Psychiatry (9 citations). Yongjun Fang has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Liucheng Rong, Yao Xue, Meilin Wang, Na Tong, Peng Wu, Zhengdong Zhang, Qin Lu, Yaping Wang, Xiaojing Sheng and Jie Huang. Their work appears in journals such as Cellular Physiology and Biochemistry, Frontiers in Immunology, Medicine, Cell Death and Disease and Gene.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.